Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 2.8.8
From GxPlex
| Document information | |
|---|---|
| Reference | ICH ICH E6 Guideline R3 (2025) |
| Validity area | ICH |
| Scope(s) | HM |
| Document name | ICH E6 Guideline |
| Version / Revision | R3 (2025) |
| Status | Current |
| Document type | International guideline |
| Language(s) | EN |
| Description | GUIDELINE FOR GOOD CLINICAL PRACTICE |
| Official source | Official link |
| Restricted access | No |
| Submitted by | Florian Adragna |
| Contributors | |
| Reference Details | |
|---|---|
| Scope | G |
| Document part | III. Annex 1
2.8.8 |
| Language | EN |
| Original entry by | Florian Adragna |
| Contributors | |
| Tags (EN) | |
| Tags (original language) | |
| Tags (FR) | |
| Comment | Emergency consent provisions when prior consent not possible |
Content
2.8.8 In emergency situations, when prior consent of the participant is not possible, the consent of the participantâs legally acceptable representative, if present, should be requested. When prior consent of the participant is not possible and the participantâs legally acceptable representative is not available, enrolment of the participant should require measures described in the protocol and/or elsewhere, with documented approval/favourable opinion by the IRB/IEC, to protect the participantâs rights, safety and well-being and to ensure compliance with applicable regulatory requirements. The participant or the participantâs legally acceptable representative should be informed about the trial as soon as possible, and consent as appropriate should be requested.